DeCure's autonomous Rare AI scientist is researching a drug-repurposing hypothesis for congenital vertical talus — screening already-approved drugs against its 1-gene Open Targets disease module to publish open-access research. Research is fast; the path to publication is funded in milestone stages.
Disease moduleCongenital vertical talus maps to a 1-gene Open Targets module — the target space DeCure's AI scientist screens approved drugs against.
DeCure.ai methodSignature reversal (LINCS) plus network proximity (STRING) rank already-approved drugs likely to perturb this module — the same engine that produces DeCure.ai's repurposing hypotheses.
Repurposing thesisScreening approved medicines against this disease module, then publishing the evidence for the strongest candidate. Known pharmacology and human exposure data make the first question sharper — they do not establish safety or efficacy in a new indication.
Research record
01
ResearchComing soon
Candidate research + dossier — target rationale, drug-repurposing thesis and evidence pack.proof: Published dossier + on-chain hash
02
ValidationComing soon
In-vitro biological validation at a contract research org (CRO).proof: CRO contract + in-vitro report
03
Peer review & paperComing soon
Peer-reviewed paper published open-access (preprint + journal).proof: DOI + open-access link + on-chain hash
Current lead
No approved-drug candidate for congenital vertical talus is corroborated in the literature DeepSearch retrieved. Some conditions are managed with non-pharmacological care — a device, surgery or physical therapy — rather than a medicine; that may be the case here, or the literature we found may simply be too sparse yet to support a drug-repurposing angle.
What the evidence adds up to
Seven patients (10 feet) with true congenital vertical talus underwent surgical correction before age two. Follow-up averaged 5.2 years. Cosmetic correction was excellent in seven of the 10 feet and good in the remaining three. The authors concluded that a single-stage procedure with less extensive surgery than previously described was sufficient.
Earlier literature is more pessimistic about non-operative treatment. A 1974 review of early manipulative treatment cited Lloyd-Roberts & Spence (1958) stating that conservative methods "have in common an unsatisfactory outcome, because the deformity was neither corrected nor significantly improved in any instance, even when treatment started within the first few weeks of life." The 1974 authors claimed new possibilities for manipulative treatment but presented only preliminary results.
A 2010 historical review notes that congenital vertical talus occurs in approximately 1 in 10,000 live births and is isolated in about 50% of cases. A family history is present in 12-20%. Outland and Sherk in 1960 described a three-year-old boy with neglected deformity in whom nonoperative treatment had failed; they performed three operations over 4½ months and achieved radiographic correction with functional and cosmetic improvement. They stated that with conservative methods "lasting correction seldom is obtained." The 2010 review mentions a more recent technique of manipulation and casting similar to the Ponseti method for clubfoot, followed by percutaneous pinning or open reduction, but notes that no follow-up data were reported and it remains unknown whether reductions will be maintained.
What is still missing is long-term follow-up data on the newer Ponseti-style manipulation and casting technique, prospective comparisons of single-stage versus two-stage surgery, and any randomised trial of conservative versus surgical treatment. Patient stratification by associated neuromuscular or genetic conditions is also absent from these reports.
Evidence
Retrieved by DeepSearch across 234,678,978 indexed works and resolved on OpenAlex — ranked by citations, including the results that did not work.
Journal of Pediatric Orthopaedics · 1987 · 76 citations
Surgical Correction of Congenital Vertical Talus Under the Age of 2 Years
AbstractSeven patients (10 feet) with true congenital vertical talus are described. The suggested pathomechanics of the condition correlated well with the rationale of surgical treatment. Correction of both forefoot and hindfoot deformities is necessary. Follow-up averaged 5.2 years. Cosmetic correction was excellent in seven of the 10 feet and good in the remaining three. These results indicate that there is no need for surgery to be performed in two stages and that it is not necessary for procedures to be as extensive as has been suggested in the literature.
Congenital Vertical Talus:<i>Reevaluation of Early Manipulative Treatment</i>
AbstractVertical talus is a rare congenital foot deformity.I t is generally agreed lhat it is difficult to obtain satisfactory correction by non-operativc treatment.I n the evaluation of different methods of conservative trcatment Lloyd-Roberts & Spence (1958) emphasized that: "they have in common an unsatisfactory outcome, because the deformity was neither corrected nor significantly improved in any instance, even when treatment started within the first few weeks of life".In a clinic with extensive experience with manipulative trcatnicnt of congenital club foot, we have made observations concerning early manipulative treatment of vertical talus indicating new possibilities for the conservative form of treatment.Thus we feel justified in reporting our preliminary results.?vi A 7' I .
Disease module: DeepOracle (Open Targets). Structures: RDKit from PubChem SMILES. Literature: retrieved by DeepSearch across 234,678,978 indexed works (targeted per-candidate search), resolved on OpenAlex.
DeCure is a research and publication project, not medical advice and not a treatment. "DeCure for X" describes a research goal, not a claim that a cure exists. Backing a cure is a contribution to fund the research — it is not an investment, and confers no yield, royalty, equity or IP ownership. Papers are published open-access by the DeCure.ai DAO.